Obstructive Sleep Apnea, Retinal Vein Occlusion, Retinal Artery Occlusion

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-06-30

Study Completion Date

2012-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Obstructive sleep apnea is a common disorder linked to serious long-term adverse health consequences; such as hypertension, metabolic dysfunction, cardiovascular disease. Retinal vascular occlusion is related to many systemic illnesses especially hypertension. Obstructive sleep apnea is also related to vascular endothelial dysfunction and vascular endothelial growth factor elevation which causes vision threatening complications of retinal vascular occlusion. Therefore the relationship between obstructive sleep apnea and retinal vascular occlusion should be studied.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prospective Observational Registry for Obstructive Sleep Apnea in Patients With Acute Myocardial Infarction

NCT03600246

Obstructive Sleep Apnea Acute Myocardial Infarction

COMPLETED

Obstructive Sleep Apnea and Endothelial Function in Patients With Resistant Hypertension

NCT01854190

Obstructive Sleep Apnea Secondary Hypertension

COMPLETED

Retinal Vascular Network and Obstructive Sleep Apnea

NCT03979001

Obstructive Sleep Apnea Syndrome

COMPLETED

Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease

NCT00984308

Obstructive Sleep Apnea Stroke Transient Ischemic Attack +1 more

COMPLETED PHASE2/PHASE3

Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study

NCT04011358

Retinal Vein Occlusion Obstructive Sleep Apnea

WITHDRAWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retinal Vascular Occlusion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Watchpat 100

Watchpat 100 is a noninvasive portable sleep monitoring device which monitors peripheral arterial tone, pulse, oxygen saturation, snoring, and body position. Patient places one probe at his or her finger and another sensor at front of the chest and Watchpat 100 monitors the patient overnight.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Watch-PAT™ 100

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any patient who visits outpatient clinic and diagnosed as retinal vascular occlusion which occurred within recent 3 months

Exclusion Criteria

* Any ocular disease other than retinal vascular occlusion (for example: floppy eyelid syndrome, uveitis, glaucoma, other retinal diseases)
* Patient who has difficulty answering the questionnaires or portable sleep monitoring
* Patient who refuses the study enroll

Minimum Eligible Age

20 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No